DR. REDDY'S LABORATORIES, INC. et al v. ASTRAZENECA AB et al

  1. May 24, 2016

    AstraZeneca Says Del. Order Ends Dr. Reddy's NJ Nexium Suit

    AstraZeneca AB on Monday urged a New Jersey federal court to dismiss Dr. Reddy's Laboratories suit alleging it wrongfully blocked the generics maker from using a purple capsule for its version of Nexium, saying a Delaware federal court already decided the issue by enjoining Dr. Reddy's use of the purple marks.

  2. January 13, 2016

    NJ Judge Stays Dr. Reddy's Purple Pill Suit Pending Appeal

    A New Jersey federal judge on Wednesday ordered a stay in a suit by Dr. Reddy's Laboratories accusing AstraZeneca AB of wrongfully blocking the generics maker from using a purple capsule for its version of Nexium, saying that the case must wait for the outcome of a similar suit between the companies in the Third Circuit.

  3. November 19, 2015

    Dr. Reddy's Sues To Use Purple Pill For Heartburn Generic

    Dr. Reddy's Laboratories Inc. has accused AstraZeneca AB of wrongfully blocking the generics maker from using a purple capsule for its version of heartburn drug Nexium, arguing the Swedish pharmaceutical giant knew the company planned to use the color.